Patent Law Weblog
Month: May 2007
-
By Christopher P. Singer — On May 7, 2007, Australian biotech companies EvoGenix Ltd. and Peptech Ltd. announced that they are planning a merger that would form one of Australia’s largest biotechnology companies. The new company, yet to be named, would continue to focus on antibody technology and protein therapeutics, in particular in…
-
By Jason Derry — Gene Logic Inc. announced today will collaborate with Abbott Laboratories to discover drug candidates that can be returned to clinical development. Gene Logic analyzes drug candidates that were once involved in clinical trials, but then were discontinued for reasons not related to safety. Abbott hopes that Gene Logic can…
-
By Kevin E. Noonan — The crisis regarding the pricing of patented drugs in poor and developing countries continues this week, with actions by current and former U.S. chief executives contributing to the situation. The U.S. Trade Representative issued a "Special 301 Report" on Monday, pursuant to the provisions of the Trade Act…
-
By Donald Zuhn — Last week, the United States Patent and Trademark Office (USPTO) published a Notice in the Federal Registrar requesting public comment on international patent law harmonization efforts. In particular, the USPTO is seeking comments on the following ten topics: (1) The "first-to-invent" rule used for determining the right to a…
-
By Christopher P. Singer — Shortly after the Supreme Court released its opinion in KSR Int’l Co. v. Teleflex, Inc., Biotechnology Industry Organization (BIO) president and CEO Jim Greenwood commented on the decision, as well as on the amicus brief the organization had previously filed on behalf of Respondent, Teleflex, Inc. Mr. Greenwood…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Shire, LLC v. Teva Pharmaceutical Industries Ltd. et. al.1:07-cv-03526; filed May 2, 2007 in the Southern District of New York Infringement of…
-
By Kevin E. Noonan — Although the contours of the Federal Circuit’s response to the Supreme Court’s obviousness decision in KSR Int’l Co. v. Teleflex, Inc. are yet to be established, the Court has developed a penchant recently (see Patent Docs previous report) for using an uncharacteristic deference to jury determinations of fact…
-
By Kevin E. Noonan — Treaties have a funny way of not having the results expected when they are signed. The Versailles Treaty and the Briand-Kellogg Pact did not prevent Germany from rearming prior to World War II; the United Nations Charter did not prevent the General Assembly from adopting resolutions contrary to…
-
May 6-9, 2007 – BIO International Convention – Boston, MA May 8, 2007 – "KSR International Co. v. Teleflex, Inc.: Discover How the High Court's Ruling Will Alter the Patent Landscape" (West LEGALworks®) May 9, 2007 – "Frontiers in Stem Cell Biology" (University of Michigan Life Sciences Institute) – Ann Arbor, MI May 17, 2007…
-
By Kevin E. Noonan — The ink is barely dry on the U.S. Supreme Court’s decision in KSR Int’l Co. v. Teleflex Inc., perhaps the most anticipated patent law decision of the year, and pundits and practitioners are trying to assess the impact of the decision on patent law and practice. It is…
Patent Docs 